The Path to Diagnosis and Treatment Among Patients With Generalized Myasthenia Gravis (gMG): Health Disparities Experienced by Racial and Ethnic Minorities From Project ASPIRE (eliminAte diSparities and Promote equIty in Rare diseasE) (P12-11.031)

To identify barriers to diagnosis and healthcare access for patients with gMG, assess whether subgroups of patients are disproportionately affected, and propose solutions to mitigate barriers.

Authors

Sheila Fifer (ORCID: https://orcid.org/0000-0003-3136-2832)
Adrian Kielhorn
Nan Jiang (ORCID: https://orcid.org/0000-0002-0671-6822)
Kelly McNeil-Posey
Kristi Mitchell (ORCID: https://orcid.org/0000-0003-4725-9194)
Stacey Tatroe
Wendy Everett
Marla Morgan

Institutions

Phoebe Putney Memorial Hospital (US)
University of Alabama at Birmingham (US)
AstraZeneca (Brazil) (BR)
Alexion Pharma (Switzerland) (CH)
HealthPartners (US)

Publication Details

Journal: Neurology
Published: 2025-04-07
DOI: https://doi.org/10.1212/wnl.0000000000208770
Primary Topic: Myasthenia Gravis and Thymoma
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

The Path to Diagnosis and Treatment Among Patients With Generalized Myasthenia Gravis (gMG): Health Disparities Experienced by Racial and Ethnic Minorities From Project ASPIRE (eliminAte diSparities and Promote equIty in Rare diseasE) (P12-11.031)

Sheila Fifer, Adrian Kielhorn, Nan Jiang, Kelly McNeil-Posey et al.

Apr 7, 2025

Neurology

Myasthenia Gravis and Thymoma

article

The Path to Diagnosis and Treatment Among Patients With Generalized Myasthenia Gravis (gMG): Health Disparities Experienced by Racial and Ethnic Minorities From Project ASPIRE (eliminAte diSparities and Promote equIty in Rare diseasE) (P12-11.031)

Sheila Fifer, Adrian Kielhorn, Nan Jiang, Kelly McNeil-Posey, Kristi Mitchell, Stacey Tatroe, Wendy Everett, Marla Morgan

April 7, 2025article en

Abstract

To identify barriers to diagnosis and healthcare access for patients with gMG, assess whether subgroups of patients are disproportionately affected, and propose solutions to mitigate barriers.

NeurologyVol. 104(7_Supplement_1)

Phoebe Putney Memorial Hospital (US), University of Alabama at Birmingham (US), AstraZeneca (Brazil) (BR), Alexion Pharma (Switzerland) (CH), HealthPartners (US)

Reduced inequalities

Openalex Percentile: Top 89%

Myasthenia Gravis and Thymoma

DOI Source OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

The Path to Diagnosis and Treatment Among Patients With Generalized Myasthenia Gravis (gMG): Health Disparities Experienced by Racial and Ethnic Minorities From Project ASPIRE (eliminAte diSparities and Promote equIty in Rare diseasE) (P12-11.031) — Sheila Fifer, Adrian Kielhorn, et al. · Neurology (2025) | TGRS Research Map | TGRS